Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2026-02-25 @ 9:40 PM
Study NCT ID:
NCT01078961
Status:
COMPLETED
Last Update Posted:
2016-06-08
First Post:
2010-03-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Sponsor:
Massachusetts General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
09-443
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None